Clinical Trial Update: VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis

View source ↗

Summary

The VICTOR trial evaluating intravenous moxifloxacin (Avelox) for acute exacerbations of chronic bronchitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Exacerbation of Chronic Bronchitis

Drugs mentioned

• Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Chronic Bronchitis, Disease Exacerbation | Status: COMPLETED